Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents

Sponsor
University Hospital, Motol (Other)
Overall Status
Completed
CT.gov ID
NCT03141580
Collaborator
professor Josef Veselka (Other), associate professor Petr Hájek (Other), Martin Horváth (Other)
52
1
1
27.6
1.9

Study Details

Study Description

Brief Summary

The 'Long-term Follow-up Near-infrared Spectroscopy and Intravascular Ultrasound Imaging of Internal Carotid Artery Stenosis Treated With Stenting' trial is an academic research project. It follows already published results of a research on carotid plaque composition in patients undergoing carotid stenting.

Patients who were treated with carotid stenting will be invited to participate on the trial. The written informed consent will be needed. The participants will undergo carotid angiography, intravascular near-infrared spectroscopy and intravascular ultrasound of the extracranial portion of the internal and common carotid artery with implanted stent.

The aim of the trial is to describe long-term change of the luminal and stent dimensions, vessel wall remodeling and plaque composition after carotid stenting. The findings will help to understand the long-term effect of carotid stenting on the carotid stenosis and mechanisms of plaque stabilization - sealing with stent.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Near-infrared spectroscopy and intravascular ultrasound (NIRS-IVUS)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Long-term Follow-up Near-infrared Spectroscopy and Intravascular Ultrasound Imaging of Internal Carotid Artery Stenosis Treated With Stenting
Actual Study Start Date :
Jul 15, 2017
Actual Primary Completion Date :
Sep 1, 2019
Actual Study Completion Date :
Nov 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study group

Subjects with carotid stent who consented to undergo near-infrared spectroscopy and intravascular ultrasound imaging.

Diagnostic Test: Near-infrared spectroscopy and intravascular ultrasound (NIRS-IVUS)
Examination of the extracranial portion of the internal and common carotid artery with pre-existing stent with NIRS-IVUS.

Outcome Measures

Primary Outcome Measures

  1. Temporal change of lipid core burden index (LCBI) [16 months]

    Difference between LCBI (a dimensionless number) within the segment of the carotid artery with implanted stent in the time point of the carotid stenting (baseline LCBI) and in the time point of study intervention (follow-up LCBI). Data from NIRS.

Secondary Outcome Measures

  1. Late lumen change [16 months]

    Difference between luminal volume (mm3) within the segment of the carotid artery with implanted stent in the time point of the carotid stenting (baseline lumen volume) and in the time point of study intervention (follow-up lumen volume). Data from IVUS.

  2. Late stent expansion [16 months]

    Difference between stent volume (mm3) within the segment of the carotid artery with implanted stent in the time point of the carotid stenting (baseline stent volume) and in the time point of study intervention (follow-up stent volume). Data from IVUS.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • previous carotid stenting

  • data from periprocedural NIRS-IVUS available

  • written informed consent

Exclusion Criteria:
  • occlusion of the carotid artery on the side of the implanted stent

  • indication for carotid intervention on the side of the implanted stent

  • high procedural risk (difficult anatomy, risk of puncture site bleeding)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Motol University Hospital Praha Czechia 15300

Sponsors and Collaborators

  • University Hospital, Motol
  • professor Josef Veselka
  • associate professor Petr Hájek
  • Martin Horváth

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Cyril štěchovský, Principal Investigator, University Hospital, Motol
ClinicalTrials.gov Identifier:
NCT03141580
Other Study ID Numbers:
  • EK-953/16
First Posted:
May 5, 2017
Last Update Posted:
Apr 29, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 29, 2020